Clinical Trials on Relapsed Advanced Lymphomas in United States
Total 30437 results
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
University of California, Los AngelesUniversity of California, San Francisco; University of California, IrvineActive, not recruitingAdvanced Cancer | Advance Care Planning | Advance DirectivesUnited States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
PharmaMarCompletedAdvanced Solid Tumors | LymphomasFrance, United States
-
New Mexico Cancer Care AllianceChristus Stehlin Foundation for Cancer ResearchCompletedAdvanced Solid Tumors | LymphomasUnited States
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumor | LymphomasFrance, Netherlands, United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Chinook Therapeutics, Inc. (formerly Aduro)Novartis PharmaceuticalsTerminatedAdvanced/Metastatic Solid Tumors or LymphomasUnited States
-
Stanford UniversityTerminatedMycosis Fungoides | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous LymphomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingLymphomas | B-cell LymphomasUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Relapsed/Refractory LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Stingthera, Inc.Merck Sharp & Dohme LLCTerminatedAdvanced Solid Tumor | Advanced LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
Adlai Nortye Biopharma Co., Ltd.RecruitingAdvanced Solid Tumor | Advanced LymphomaUnited States, China
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Kymera Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Acute Lymphocytic Leukemia | Lymphomas | Myeloid MalignanciesUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
Curis, Inc.CompletedAdvanced Solid Tumors or LymphomasUnited States, Spain, Korea, Republic of, United Kingdom
-
Bristol-Myers SquibbTerminatedAdvanced Solid Tumors | Advanced B-cell NHLUnited States, France, Spain, Germany
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
National Cancer Institute (NCI)RecruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | B-Cell Non-Hodgkin Lymphoma | Metastatic Pancreatic Carcinoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Refractory T-Cell... and other conditionsUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
MedImmune LLCCompletedRelapsed/Refractory Aggressive B-cell LymphomasUnited States
-
CStone PharmaceuticalsRecruitingAdvanced Solid Tumor | Advanced LymphomaChina, Australia, United States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)SuspendedLymphoma | Advanced Solid TumorUnited States
-
Eli Lilly and CompanyCompletedColorectal Cancer | Mantle Cell Lymphoma | Advanced CancerUnited States, France, United Kingdom
-
ADC Therapeutics S.A.Withdrawn
-
Ahmed Galal, MDWithdrawnB Cell LymphomasUnited States
-
Cornerstone PharmaceuticalsCompletedLymphoma | Metastatic Cancer | Advanced Cancer | Solid Tumors | Advanced MalignanciesUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Alaunos TherapeuticsUnknownAdvanced CancerUnited States
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
Epizyme, Inc.CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Primary Mediastinal LymphomaUnited States
-
Spectrum Pharmaceuticals, IncTerminatedNon-Hodgkin's Lymphoma | Advanced Solid TumorsUnited States
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States